Axsome Therapeutics, Inc.

AXSM

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001579428

SEC filings (opens in a new tab)

In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Axsome Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of AXSM: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	167	2	175	+10
Shares	18.6M	115.4K	19.1M	+592.8K (+3.2%)
Value	$704.2M	$4.36M	$787.4M	+$87.5M (+12.5%)

2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Axsome Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to AXSM in Q1 2022
Institution	Shares	Value	% of portfolio
Adage Capital Partners GP, L.L.C.	650,000	$26.9M	0.05%
Mangrove Partners	181,695	$7.52M	0.60%
D. E. Shaw & Co., Inc.	155,392	$6.43M	0.01%
Ghost Tree Capital, LLC	94,500	$3.91M	1.94%
TAP Consulting, LLC	38,429	$1.59M	0.42%
Capital Fund Management S.A.	32,178	$1.33M	0.04%
Raymond James Financial Services Advisors, Inc.	17,692	$732.0K	0.00%
Panagora Asset Management Inc	12,720	$526.0K	0.00%
ExodusPoint Capital Management, LP	11,627	$481.0K	0.01%
B. Metzler seel. Sohn & Co. AG	9,754	$404.0K	0.01%
Connor, Clark & Lunn Investment Management Ltd.	9,195	$381.0K	0.00%
FORA Capital, LLC	8,742	$350.0K	0.06%
Jefferies Group LLC	8,350	$345.6K	0.01%
Walleye Capital LLC	8,295	$343.0K	0.01%
Schonfeld Strategic Advisors LLC	7,300	$302.0K	0.00%
Y-Intercept (Hong Kong) Ltd	6,774	$280.0K	0.06%
Bayesian Capital Management, LP	5,900	$244.0K	0.04%
Teacher Retirement System of Texas	5,104	$211.0K	0.00%
Principal Financial Group Inc	5,088	$211.0K	0.00%
Janus Henderson Group PLC	4,958	$205.0K	0.00%
Financial Consulate, Inc	4,865	$201.0K	0.08%
Amalgamated Bank	4,525	$187.0K	0.00%
Amalgamated Financial Corp.	4,525	$187.0K	0.00%
Quantbot Technologies LP	3,956	$163.0K	0.01%
Allspring Global Investments Holdings, LLC	3,421	$141.0K	0.00%
Leonteq Securities AG	1,100	$45.5K	0.00%
Aquatic Capital Management LLC	700	$29.0K	0.04%
Financial Management Professionals, Inc.	100	$4.00K	0.00%
Siena Capital LLC	15	$1.00K	0.00%
GPS Wealth Strategies Group, LLC	11	$0	0.00%
International Biotechnology Trust PLC	14,000	–	–

Sold out (21)

Institutions that held Axsome Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of AXSM in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Susquehanna International Group, LLP	116,144	$4.39M
Perceptive Advisors LLC	80,420	$3.04M
Moody Aldrich Partners LLC	42,871	$1.62M
CSS LLC	18,549	$701.0K
Maven Securities LTD	17,017	$643.0K
Boothbay Fund Management, LLC	13,447	$508.0K
HAP Trading, LLC	11,580	$437.0K
Trexquant Investment LP	8,508	$321.0K
Seven Eight Capital, LP	8,384	$317.0K
Glenmede Trust Co NA	5,535	$209.0K
Dynamic Technology Lab Private Ltd	5,382	$204.0K
STRS Ohio	4,600	$173.0K
Proequities, Inc.	2,800	$106.0K
Bank Julius Baer & Co. Ltd, Zurich	450	$17.0K
Umb Bank N A	370	$14.0K
Tradewinds Capital Management, LLC	300	$11.0K
Migdal Insurance & Financial Holdings Ltd.	249	$9.00K
Dark Forest Capital Management LP	141	$5.00K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	130	$4.00K
Parallel Advisors, LLC	92	$3.00K
Investmark Advisory Group LLC	100	$3.00K

Not filed for Q1 2022 yet (2)

Institutions that held Axsome Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AXSM in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
First Midwest Bank Trust Division	115,028	$4.35M
NEXT Financial Group, Inc	400	$15.0K